Patient-initiated Dermatology Research Needs Allergy UK Participants
The International Alliance of Dermatology Patient Organizations (also known as GlobalSkin) is inviting Allergy UK patient community members to participate in a unique research project where the dermatology patient is the expert and their opinion truly matters.
With the help and guidance of dermatology patient around the world, the Global Research on the Impact of Dermatological Diseases (GRIDD) project aims to develop a global instrument to measure the impact of living with skin diseases on a global scale. Further, it will document patient experiences including the extent of disease impact and burden for patients and their families.
Dermatology patients are needed!
The GRIDD project is currently in Phase 3 and focused on a Patient Data Verification Delphi. The goal of the Delphi is to gather impact data from 2000 adult dermatology patients representing as many different dermatological diseases as possible and from all regions of the globe.
As a participant, you would be asked to take part in two surveys – one now and then one in two months. The survey will ask you questions about your experience living with atopic dermatitis and how it impacts your life and how much of a burden it is on your family.
By taking part in the Delphi and completing the two surveys, you will be making an important contribution to improving the lives of atopic dermatitis patients and all dermatology patients around the world now and in the future.
Make YOUR IMPACT – Take the Delphi Survey Now
The survey is live for 6 weeks from December 2020 to mid-January 2021.
For more information about GRIDD or GlobalSkin please visit – https://globalskin.org